The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Open accessAbstract
Introduction: Recent studies have identified subtypes of small cell lung carcinoma (SCLC) defined by RNA expression of ASCL1, NEUROD1, POU2F3 and YAP1 transcriptional regulators. There are only limited data on distribution of these markers at the protein level and associated pathologic characteristics in clinical SCLC samples. Methods: Expression of ASCL1, NEUROD1, POU2F3 and YAP1 was analyzed by immunohistochemistry in 174 SCLC patient samples. Subtypes defined by these markers were correlated with histologic characteristics, expression of neuroendocrine markers (synaptophysin, chromogranin A, CD56, INSM1) and other SCLC markers including neuroendocrine phenotype-associated marker DLL3. Results: ASCL1 and NEUROD1 expression had the following distribution: ASCL1+/NEUROD1− 41%, ASCL1+/NEUROD1+ 37%, ASCL1−/NEUROD1+ 8% and ASCL1−/NEUROD1− 14%. Based on the relative expression, 69% of cases were ASCL1-dominant and 17% NEUROD1-dominant. POU2F3 was expressed in 7% of SCLC, and was mutually exclusive of ASCL1 and NEUROD1. YAP1 was expressed at low levels, primarily in combined SCLC, and was not exclusive of other subtypes. Both ASCL1-dominant and NEUROD1-dominant subtypes were associated with neuroendocrine markerhigh/DLL3high profile, whereas POU2F3 and other ASCL1/NEUROD1-double-negative tumors were neuroendocrine markerlow/DLL3low. Conclusions: This is the first comprehensive immunohistochemical and histopathologic analysis of novel SCLC subtypes in patient samples. We confirm that ASCL1/NEUROD1-double-negative tumors represent a distinct neuroendocrine-low subtype of SCLC which is either uniquely associated with POU2F3 or lacks a known dominant regulator. Expression profiles of these markers appear more heterogeneous in native samples than in experimental models, particularly in regard to high prevalence of ASCL1/NEUROD1 co-expression. These findings may have prognostic and therapeutic implications and warrant further clinical investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Self-citationTravis, W. D., Brambilla, E., Burke, A. P., Marx, A., & Nicholson, A. G. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000663 · Cited by 1,905
Self-citationWHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Self-citationIntegrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Rudin, C. M., Poirier, J. T., Byers, L. A., Dive, C., Dowlati, A., George, J., Heymach, J. V., Johnson, J. E., Lehman, J. M., MacPherson, D., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0133-9 · Cited by 1,254
Self-citationTuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
von Moltke, J., Ji, M., Liang, H.-E., & Locksley, R. M. (2016) · Nature · doi:10.1038/nature16161 · Cited by 1,230
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites
Gerbe, F., Sidot, E., Smyth, D. J., Ohmoto, M., Matsumoto, I., Dardalhon, V., Cesses, P., Garnier, L., Pouzolles, M., Brulin, B., et al. (2016) · Nature · doi:10.1038/nature16527 · Cited by 961
Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut
Howitt, M. R., Lavoie, S., Michaud, M., Blum, A. M., Tran, S. V., Weinstock, J. V., Gallini, C. A., Redding, K., Margolskee, R. F., Osborne, L. C., et al. (2016) · Science · doi:10.1126/science.aaf1648 · Cited by 928
Fedchenko, N., & Reifenrath, J. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0221-9 · Cited by 808
Saunders, L. R., Bankovich, A. J., Anderson, W. C., Aujay, M. A., Bheddah, S., Black, K., Desai, R., Escarpe, P. A., Hampl, J., Laysang, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9459 · Cited by 600
Self-citationMollaoglu, G., Guthrie, M. R., Böhm, S., Brägelmann, J., Can, I., Ballieu, P. M., Marx, A., George, J., Heinen, C., Chalishazar, M. D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.005 · Cited by 588
Ireland, A. S., Micinski, A. M., Kastner, D. W., Guo, B., Wait, S. J., Spainhower, K. B., Conley, C. C., Chen, O. S., Guthrie, M. R., Soltero, D., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.001 · Cited by 508
Borromeo, M. D., Savage, T. K., Kollipara, R. K., He, M., Augustyn, A., Osborne, J. K., Girard, L., Minna, J. D., Gazdar, A. F., Cobb, M. H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.081 · Cited by 503
Unravelling the biology of SCLC: implications for therapy
Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T., & Rudin, C. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.71 · Cited by 490
Self-citationGazdar, A. F., Carney, D. N., Nau, M. M., & Minna, J. D. (1985) · PubMed · Cited by 477
Neuroendocrine Tumors of the Lung: An Update
Rekhtman, N. (2010) · Archives of Pathology and Laboratory Medicine · doi:10.5858/2009-0583-rar.1 · Cited by 445
Self-citationPOU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
Huang, Y.-H., Klingbeil, O., He, X.-Y., Wu, X. S., Arun, G., Lu, B., Somerville, T. D. D., Milazzo, J. P., Wilkinson, J. E., Demerdash, O. E., et al. (2018) · Genes & Development · doi:10.1101/gad.314815.118 · Cited by 422
George, J., Walter, V., Peifer, M., Alexandrov, L. B., Seidel, D., Leenders, F., Maas, L., Müller, C., Dahmen, I., Delhomme, T. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03099-x · Cited by 377
Self-citationA Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H. B., Meuwissen, R., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.021 · Cited by 369
Zhang, W., Girard, L., Zhang, Y.-A., Haruki, T., Papari-Zareei, M., Stastny, V., Ghayee, H. K., Pacak, K., Oliver, T. G., Minna, J. D., et al. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.02.02 · Cited by 263
Regulation of immune responses by tuft cells
Schneider, C., O’Leary, C. E., & Locksley, R. M. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0176-x · Cited by 262
Poirier, J. T., Gardner, E. E., Connis, N., Moreira, A. L., de Stanchina, E., Hann, C. L., & Rudin, C. M. (2015) · Oncogene · doi:10.1038/onc.2015.38 · Cited by 248
Self-citationTargeting NOTCH activation in small cell lung cancer through LSD1 inhibition
Augert, A., Eastwood, E., Ibrahim, A. H., Wu, N., Grunblatt, E., Basom, R., Liggitt, D., Eaton, K. D., Martins, R., Poirier, J. T., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau2922 · Cited by 238
Self-citationSkn-1a (Pou2f3) specifies taste receptor cell lineage
Matsumoto, I., Ohmoto, M., Narukawa, M., Yoshihara, Y., & Abe, K. (2011) · Nature Neuroscience · doi:10.1038/nn.2820 · Cited by 206
Rooper, L. M., Sharma, R., Li, Q. K., Illei, P. B., & Westra, W. H. (2017) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000916 · Cited by 182
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
Poirier, J. T., George, J., Owonikoko, T. K., Berns, A., Brambilla, E., Byers, L. A., Carbone, D., Chen, H. J., Christensen, C. L., Dive, C., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.01.016 · Cited by 173
Self-citationSimpson, K. L., Stoney, R., Frese, K. K., Simms, N., Rowe, W., Pearce, S. P., Humphrey, S., Booth, L., Morgan, D., Dynowski, M., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0046-2 · Cited by 173
Tuft Cells—Systemically Dispersed Sensory Epithelia Integrating Immune and Neural Circuitry
O'Leary, C. E., Schneider, C., & Locksley, R. M. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041505 · Cited by 170
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
McColl, K., Wildey, G., Sakre, N., Lipka, M. B., Behtaj, M., Kresak, A., Chen, Y., Yang, M., Velcheti, V., Fu, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20572 · Cited by 158
Rudin, C. M., Poirier, J. T., Senzer, N. N., Stephenson, J., Loesch, D. M., Burroughs, K. D., Reddy, P. S., Hann, C. L., & Hallenbeck, P. L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1706 · Cited by 153
Self-citationYamashita, J., Ohmoto, M., Yamaguchi, T., Matsumoto, I., & Hirota, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189340 · Cited by 149
Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
Poirier, J. T., Dobromilskaya, I., Moriarty, W. F., Peacock, C. D., Hann, C. L., & Rudin, C. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt130 · Cited by 133
Self-citationWooten, D. J., Groves, S. M., Tyson, D. R., Liu, Q., Lim, J. S., Albert, R., Lopez, C. F., Sage, J., & Quaranta, V. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007343 · Cited by 129
Loss of YAP 1 defines neuroendocrine differentiation of lung tumors
Ito, T., Matsubara, D., Tanaka, I., Makiya, K., Tanei, Z., Kumagai, Y., Shiu, S., Nakaoka, H. J., Ishikawa, S., Isagawa, T., et al. (2016) · Cancer Science · doi:10.1111/cas.13013 · Cited by 114
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Taniguchi, H., Sen, T., & Rudin, C. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00741 · Cited by 112
Self-citationThe Mysterious Pulmonary Brush Cell
REID, L. M., Meyrick, B. O., Antony, V. B., Chang, L.-Y., Crapo, J. D., & Reynolds, H. Y. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-203ws · Cited by 110
Cardnell, R. J., Li, L., Sen, T., Bara, R. O., Tong, P., Fujimoto, J., Ireland, A. S., Guthrie, M. R., Bheddah, S., Banerjee, U., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20621 · Cited by 91
Self-citationYamaguchi, T., Yamashita, J., Ohmoto, M., Aoudé, I., Ogura, T., Luo, W., Bachmanov, A. A., Lin, W., Matsumoto, I., & Hirota, J. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-13 · Cited by 83
Hermans, B. C. M., Derks, J. L., Thunnissen, E., van Suylen, R. J., den Bakker, M. A., Groen, H. J. M., Smit, E. F., Damhuis, R. A. M., van den Broek, E. C., Rüland, A., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.10.010 · Cited by 69
Tuft cells: From the mucosa to the thymus
Nevo, S., Kadouri, N., & Abramson, J. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.02.003 · Cited by 62
Ohmoto, M., Yamaguchi, T., Yamashita, J., Bachmanov, A. A., Hirota, J., & Matsumoto, I. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.130454 · Cited by 45
Horie, M., Miyashita, N., Mattsson, J. S. M., Mikami, Y., Sandelin, M., Brunnström, H., Micke, P., Nagase, T., & Saito, A. (2018) · The Journal of Pathology · doi:10.1002/path.5109 · Cited by 21
Cited by
Rudin, C. M., Brambilla, E., Faivre-Finn, C., & Sage, J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00235-0 · Cited by 1,570
Self-citationThe 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Nicholson, A. G., Tsao, M. S., Beasley, M. B., Borczuk, A. C., Brambilla, E., Cooper, W. A., Dacic, S., Jain, D., Kerr, K. M., Lantuejoul, S., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.11.003 · Cited by 1,554
Self-citationOverview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Rindi, G., Mete, O., Uccella, S., Basturk, O., La Rosa, S., Brosens, L. A. A., Ezzat, S., de Herder, W. W., Klimstra, D. S., Papotti, M., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09708-2 · Cited by 1,036
Gay, C. M., Stewart, C. A., Park, E. M., Diao, L., Groves, S. M., Heeke, S., Nabet, B. Y., Fujimoto, J., Solis, L. M., Lu, W., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.014 · Cited by 962
Chan, J. M., Quintanal-Villalonga, Á., Gao, V. R., Xie, Y., Allaj, V., Chaudhary, O., Masilionis, I., Egger, J., Chow, A., Walle, T., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.008 · Cited by 434
Self-citation
Metadata
- Authors
- Baine, M. K., Hsieh, M.-S., Lai, W. V., Egger, J. V., Jungbluth, A. A., Daneshbod, Y., Beras, A., Spencer, R., Lopardo, J., Bodd, F., Montecalvo, J., Sauter, J. L., Chang, J. C., Buonocore, D. J., Travis, W. D., Sen, T., Poirier, J. T., Rudin, C. M., & Rekhtman, N.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 15
- Issue
- 12
- Pages
- 1823-1835
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W3090613431
- Cited by
- 522
- References
- 43
- FWCI
- 17.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.